Barinthus Biotherapeutics
NEWS
Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices.
Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research, Vaccitech Oncology Limited, has entered into a clinical partnership with Cancer Research UK to develop VOLT’s VTP-600 immunotherapy as a treatment option for patients with non-small cell lung cancer.
Companies from across the globe provide updates on their business and product pipelines.
Companies from across the globe provide updates on their businesses and pipelines.
Vaccitech progresses clinical development of Universal Influenza A Vaccine (VTP-100) in Belgium and Australia and expects top-line data in early 2020
Biopharma companies strengthen their leadership and boards with these appointments.
Vaccitech announced that it has appointed Bill Enright as its new Chief Executive Officer.
The 2017/2018 influenza season was considered one of the worst, made more so by the ineffectiveness of the season’s flu vaccine. The FDA is focusing partially on simply determining why this year’s flu vaccine missed the mark.
The company says the vaccine takes a novel approach.
JOBS
IN THE PRESS